TGT:NYSETarget Corporation Analysis
Data as of 2026-03-10 - not real-time
$120.14
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Target Corp (TGT) is riding a solid short‑term technical rally – the 20‑day SMA (≈116) sits above the 50‑day (≈110) and 200‑day (≈99) averages, the MACD line is bullish and volume is increasing. Momentum indicators remain strong with an RSI of 62.7 and price comfortably above the identified support at $111, though resistance near $126 looms.
Fundamentally, the stock appears stretched: the DCF‑derived fair value of roughly $43 is far below the current market price of $120, yielding a modest upside of only ~3% versus a sizeable valuation premium. Earnings beat expectations, Q4 sales met guidance and analysts have upgraded the outlook to Outperform, highlighting a turnaround narrative and a robust dividend yield of 3.8% with a 55% payout ratio. While the defensive consumer sector cushions downside, revenue contraction (‑1.5%) and a high debt‑to‑equity ratio (>125) temper optimism for long‑run appreciation.
Fundamentally, the stock appears stretched: the DCF‑derived fair value of roughly $43 is far below the current market price of $120, yielding a modest upside of only ~3% versus a sizeable valuation premium. Earnings beat expectations, Q4 sales met guidance and analysts have upgraded the outlook to Outperform, highlighting a turnaround narrative and a robust dividend yield of 3.8% with a 55% payout ratio. While the defensive consumer sector cushions downside, revenue contraction (‑1.5%) and a high debt‑to‑equity ratio (>125) temper optimism for long‑run appreciation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish technical setup (SMA crossover, MACD, rising volume)
- Recent earnings beat and analyst upgrade to Outperform
- Support level near $111 providing downside cushion
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Attractive dividend yield with sustainable payout
- Defensive consumer sector positioning
- Valuation premium remains large relative to DCF fair value
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Significant overvaluation versus intrinsic value
- Revenue decline and high leverage (debt‑to‑equity >125)
- Limited growth upside despite short‑term momentum
Key Metrics & Analysis
Financial Health
Revenue Growth-1.50%
Profit Margin3.54%
P/E Ratio14.8
ROE24.03%
ROA5.09%
Debt/Equity125.52
P/B Ratio3.4
Op. Cash Flow$6.6B
Free Cash Flow$2.5B
Technical Analysis
TrendBullish
RSI62.7
Support$111.11
Resistance$126.00
MA 20$116.28
MA 50$109.88
MA 200$99.01
MACDBullish
VolumeIncreasing
Fear & Greed Index79.04
Valuation
Fair Value$43.22
Target Price$123.66
Upside/Downside2.93%
GradeOvervalued
TypeValue
Dividend Yield3.80%
Risk Assessment
Beta0.95
Volatility36.08%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.